AKT1 and hepatocellular carcinoma: Activation of this pathway is usually determined by immunohistochemical studies of protein phosphorylation in HCC tumor tissue, because genetic aberrations of IGFR and PI3K/Akt/mTOR pathways are rare in HCC [31,32].